Table 2.
Dosing regimens for the study patients (mean ± SD, range).
| Variable | Lorazepam Learning group (n = 28) | Lorazepam Evaluation group (n = 31) | Midazolam Learning group (n = 21) | Midazolam Evaluation group (n = 33) |
|---|---|---|---|---|
| Duration of administration (h) | 149 ± 157 (24–572) | 141 ± 117 (24–583) | 134 ± 172 (24–715) | 141 ± 101 (30–426) |
| Amount of medication (mg day−1) | 18 ± 13.9 (3.8–63.2) | 23.1 ± 14.4 (5.4–59.3) | 497 ± 417 (119–1682) | 372 ± 256 (102–1190) |
| Number of infusion rate adjustments | 5 ± 4 (0–21) | 4 ± 4 (0–18) | 6 ± 9 (0–34) | 4 ± 3 (0–13) |